Carrum Health announced the appointment of former ConsumerMedical executive Randy K. Hawkins, M.D., FACHE as the company’s Chief Medical Officer (CMO). With nearly three decades of clinical experience as an anesthesiologist and senior healthcare technology executive, Dr. Hawkins will advance Carrum’s mission to provide rigorous analysis of providers and provider organizations and expand a world-class COE network across the country.
Carrum’s COE partners represent the top 10% in their respective specialties and are evaluated at the individual surgeon level. Through partnership, Carrum COEs are given incentives to provide the most appropriate care in all cases, regardless of whether a patient has been recommended for surgical intervention by another physician. This results in 30% of Carrum members being redirected to less invasive, less costly care.
“I had the privilege of impacting many lives as an anesthesiologist, but I was ultimately drawn to the business side of healthcare, where I saw an opportunity to make an even greater impact to help rehabilitate the current model. This involves aligning quality care with reasonable costs – without ever losing sight of the patient experience,” said Hawkins. “Carrum is the first company I’ve seen that seeks to address both the cost and quality components of the healthcare equation. Sach and his team built a vehicle that is delivering true value-based care, and the talent and experience of this team are unparalleled in the industry. I am honored to join Carrum Health to help deliver the highest quality, best care for our members.”
Healthmine will host the last webinar in their 3-part 2022 Star Ratings Webinar Series on Wednesday, November 17th. In this hour-long session, Healthmine’s industry experts will be available to field questions regarding current and new measures, as well as share detailed insights into best practices for Star Ratings success in 2022. No question is off limits!
Sign up to attend live or receive the on-demand recordings to watch at your convenience.
To register, click here.
1upHealth has hired Dr. Donald Rucker, former National Coordinator for Health Information Technology in the U.S. Department of Health and Human Services as Chief Strategy Officer. 1upHealth has a Fast Healthcare Interoperability Resources (FHIR) platform for APIs. It connects payers, providers, patients, life sciences and app developers within an interoperability network.
Earlier this year, the company raised a $25 million Series B round led by F-Prime Capital. Existing investors, Jackson Square Ventures, Eniac Ventures, and Social Leverage also participated.
Ricky Sahu, CEO and Founder of 1upHealth, said in a press release: “Dr. Rucker brings the unique perspective of a physician, software engineer, product developer, and policy leader at the highest levels, and few people in the world have this breadth of experience and understanding of the industry. As the father of ONC’s Cures Act Final Rule, Dr. Rucker knows that was just the first step—organizations need to go beyond merely complying with the rule to receive the maximum benefit from this transformative technology.”
To read more, click here.
DeepCure, which is developing novel, small molecule therapeutics using the world’s largest AI drug discovery engine, has announced the closing of a $40 million Series A financing round. Morningside Ventures led the funding round, with participation from existing investors TLV Partners, Sapir Venture Partners, and Benon Group Ltd. DeepCure has raised $47 million in financing to date. In addition to its AI-driven drug discovery platform and automated, robotic laboratory, the company is developing several novel preclinical candidates across different “undruggable” classes, ranging from polypharmacology programs to protein-protein interactions and previously “impossible” specificity challenges critical in various indications in areas of high unmet medical need.
To read more, click here.
Picture: akindo, Getty Images
